Cite
MLA Citation
Badr Al-Bawardy et al.. “P167 VEDOLIZUMAB TROUGH LEVELS AND ANTIBODIES IN INFLAMMATORY BOWEL DISEASE: UPDATED INITIAL EXPERIENCE.” Inflammatory bowel diseases, vol. 24, n.d., pp. S62–S63. http://access.bl.uk/ark:/81055/vdc_100095477202.0x000025